NCT00809497View on ClinicalTrials.gov

A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases

PHASE3CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

January 31, 2011

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Propionyl-L-carnitine Tablets

500mg tablets, oral administration of 2g daily

Trial Locations (1)

100053

Xuanwu Hospital Capital Medical University, Beijing

Sponsors
All Listed Sponsors
collaborator

Nanjing Medical University

OTHER

lead

Lee's Pharmaceutical Limited

INDUSTRY

NCT00809497 - A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases | Biotech Hunter | Biotech Hunter